Allarity Therapeutics, Inc. - Common stock (ALLR)
1.6000
+0.0600 (3.90%)
NASDAQ · Last Trade: Sep 2nd, 6:50 PM EDT
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · August 27, 2025
Via Benzinga · August 27, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · August 26, 2025
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · August 26, 2025
Why Did Allarity Therapeutics Stock Double In Value Today?stocktwits.com
Via Stocktwits · August 26, 2025

Via Benzinga · September 16, 2024
Via Benzinga · August 26, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · August 26, 2025
Via Benzinga · August 26, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via Chartmill · August 26, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · August 26, 2025
Via Benzinga · August 26, 2025
U.S. stock futures slipped on Monday following Friday's mixed moves. Futures of major benchmark indices were lower.
Via Benzinga · August 18, 2025
Via Benzinga · August 18, 2025
Via Benzinga · July 28, 2025
U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.
Via Benzinga · April 1, 2025
Via Benzinga · April 1, 2025
Via Benzinga · March 24, 2025

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among Stocktwits users for the week ended March 7, 2025.
Via Stocktwits · March 10, 2025

Via Benzinga · September 19, 2024

Via Benzinga · September 17, 2024

ALLR stock results show that Allarity Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 6, 2024

Chinese EV stocks are falling on Wednesday as a negative earnings report from Telsa and delays from GM are dragging down the sector.
Via InvestorPlace · July 24, 2024